The field of pharmacological treatment strategies for urogenital disorders is rapidly evolving, with new drug classes, targeted therapies, and innovative treatment modalities emerging. This topic will ...
Future Cardiol. 2013;9(3):335-349. Research into prostacyclin analogs for the treatment of WHO Group 2 PH has been limited, likely due to the early termination of the FIRST trial. [55] This study ...
Comparative and combination studies highlight the importance of matching alcoholic patients with pharmacologic therapies ... level of consumption and goals of treatment. Improved descriptions ...
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the ...
In animal studies, boosting serotonin in the cells that line the gut reduced anxious and depressive-like behaviors without causing cognitive or gastrointestinal side effects.